IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 4, Pages e1293210
Publisher
Informa UK Limited
Online
2017-02-17
DOI
10.1080/2162402x.2017.1293210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
- (2016) Nicolas Dulphy et al. Frontiers in Immunology
- NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation
- (2016) Paola Vacca et al. Frontiers in Immunology
- Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias
- (2015) Gabriella Pietra et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy
- (2015) K. Pilipow et al. CANCER RESEARCH
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- The brave new world of innate lymphoid cells
- (2015) Gérard Eberl et al. NATURE IMMUNOLOGY
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- Trial Watch: Adoptive cell transfer for oncological indications
- (2015) Fernando Aranda et al. OncoImmunology
- Trial Watch—Immunostimulation with cytokines in cancer therapy
- (2015) Erika Vacchelli et al. OncoImmunology
- Defective Infiltration of Natural Killer Cells in MICA/B-Positive Renal Cell Carcinoma Involves β2-Integrin-Mediated Interaction
- (2015) Giuseppe Sconocchia et al. NEOPLASIA
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
- (2014) Jeffrey W. Leong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
- (2014) Michele Ardolino et al. JOURNAL OF CLINICAL INVESTIGATION
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
- (2014) Antoine Marçais et al. NATURE IMMUNOLOGY
- Development of human natural killer cells and other innate lymphoid cells
- (2014) Elisa Montaldo et al. SEMINARS IN IMMUNOLOGY
- Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
- (2014) Lorenzo Moretta et al. Frontiers in Immunology
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma
- (2013) Jacek Jan Sznurkowski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK cells from pleural effusions are potent antitumor effector cells
- (2013) Magali Terme et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Novel immune modulators used in hematology: impact on NK cells
- (2013) Stephanie Krieg et al. Frontiers in Immunology
- NK cells from malignant pleural effusions are potent antitumor effectors
- (2013) Paola Vacca et al. OncoImmunology
- NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
- (2012) Paola Vacca et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
- (2011) N. Halama et al. CLINICAL CANCER RESEARCH
- Interleukin 15 as a promising candidate for tumor immunotherapy
- (2011) Marek Jakobisiak et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging
- (2011) Judith Eckl et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN- on activation
- (2010) A. De Maria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New views on natural killer cell-based immunotherapy for melanoma treatment
- (2010) Shannon Burke et al. TRENDS IN IMMUNOLOGY
- Resolution of massive pleural effusion due to lymphoma with intrapleural interleukin-2
- (2009) Dahlia Elkadi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
- (2009) Miroslaw J. Szczepanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In vivotumor cell rejection induced by NK cell inhibitory receptor blockade: Maintained tolerance to normal cells even in the presence of IL-2
- (2009) Gustaf Vahlne et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cytokine-induced memory-like natural killer cells
- (2009) Megan A. Cooper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started